Zolpimist and Breastfeeding

Clinical studies on breastfeeding and Zolpimist (zolpidem oral spray) show that the medication passes through breast milk in humans. Since only a small amount of the drug actually reaches the breast milk, however, Zolpimist is probably safe for use while breastfeeding. Before starting this medication, breastfeeding women should talk to their healthcare providers about any potential risks associated with using this medicine.

Is Taking Zolpimist While Breastfeeding Safe?

Zolpimist® (zolpidem oral spray) passes through breast milk in breastfeeding women. However, this medication is often considered to be compatible with breastfeeding. If you are breastfeeding, talk with your healthcare provider before taking Zolpimist.

Potential Problems With Zolpimist and Breastfeeding

The American Academy of Pediatrics classifies zolpidem (the active ingredient in Zolpimist) as being compatible with breastfeeding. The medication has a short half-life (meaning that the body eliminates it very quickly), and only a small amount of the drug actually reaches the breast milk. However, it is still a good idea to watch for any possible side effects in a breastfed infant, such as drowsiness or poor feeding.

Talking With Your Healthcare Provider

You should talk with your healthcare provider about breastfeeding and Zolpimist. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, the two of you can make a shared decision that is right for you.
7 Easy Tips for Starting Solids

Zolpimist Medication Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2019 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.